Overview

TSX-V:TBP OTCQB:TBPMF

Corporate Overview

GLOBAL LEADER IN CANNABINOID-DERIVED DRUG DISCOVERY & DEVELOPMENT

Tetra Bio-Pharma is focused on drug development programs in Chronic Pain, Oncology and Ophthalmic, aimed at bringing novel drugs and treatments to patients and their healthcare providers.

Invest in TBP

TBP has one of the most advanced pipelines among companies in North America, working with Health Canada and the FDA on clinical trial programs with cannabinoid-derived medicines.

TBP’s cannabinoid-derived medicines target medical indications representing addressable markets of over $20 billion, supported by the urgent need for non-opioid alternatives to treat pain and inflammation.

TBP is building sustainable value for shareholders with an extensive and leading portfolio of cannabinoid-derived drugs, valuable intellectual properties, spearheaded by a solid scientific and regulatory team.

Latest News

View all news

Latest Presentation

Upcoming Events

View All Events

Latest Quarterly Reports

View All Financial Reports